title: Effect of a phosphate supplement on urine pH in patients with neurogenic bladder receiving intermittent catheterization.
abstract: METHODS
  Pilot study; prospective design.
  
  
  METHODS
  University Hospital, Virginia, USA.
  
  
  OBJECTIVE
  To examine a phosphorus supplement as a urine-acidifying agent in patients with neurogenic bladder on clean intermittent catheterization.
  
  
  METHODS
  Seven patients were followed for 4 weeks. For the first week of study urine pH was measured three times a day: first morning urine sample, afternoon sample, evening sample. For the second and third weeks urine pH was measured and the patients drank a phosphorus supplement three times a day. For the fourth week of study the patients did not take the phosphorus supplement but the measurement of urine pH was continued. The patients were visited in their homes twice a week. During each visit a sample of urine was collected for culture. A supplement container count was performed and urine pH recordings were checked.
  
  
  RESULTS
  There was no significant change in urine pH during the 2-week period when a patient was on phosphorus supplementation compared to when the patient was off supplementation. In addition, urine acidification was not achieved over the time period when urine pH was monitored.
  
  
  CONCLUSIONS
  Phosphate supplementation had no effect on urine pH in patients with neurogenic bladder.
authors.affiliation: Department of Pediatrics, University of Virginia, Charlottesville, VA 22908-0699, USA.
authors.forename: T A
authors.initials: TA
authors.lastname: Schlager
authors.forename: K
authors.initials: K
authors.lastname: Ashe
authors.forename: J O
authors.initials: JO
authors.lastname: Hendley
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001437:Bacteriuria / Q000517:prevention & control* / Q000652:urine*; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D010710:Phosphates / Q000008:administration & dosage*; D010865:Pilot Projects; D011446:Prospective Studies; D013119:Spinal Cord Injuries / Q000150:complications / Q000652:urine; D016896:Treatment Outcome; D001750:Urinary Bladder, Neurogenic / Q000150:complications / Q000178:diet therapy* / Q000628:therapy / Q000652:urine*; D014546:Urinary Catheterization / Q000379:methods; D014556:Urine / Q000737:chemistry*
chemical_list: D010710:Phosphates